Events Speakers Talks
 

Speakers

Sort by
Newest
Trending
1-13 of 13
1-13 of 13
Filter
Chris Hampton
Co-Owner at Hampton's Choice Holdings CBD
alternative medicine, anti-inflammatory, bong, cannabidiol, cannabis, cannabis (drug), dispensary, dose (biochemistry), kentucky, medical school, medicine, nursing, ondansetron, opiate, over-the-counter drug, physician, prescription drug, psychopharmacology, research, social stigma, specialty (medicine), substance abuse, tetrahydrocannabinol, therapy
Dave Charnick
Cannabinoid Industry Specialist at Volcanic Green Holdings
alternative medicine, anti-inflammatory, bong, cannabidiol, cannabis, cannabis (drug), dispensary, dose (biochemistry), kentucky, medical school, medicine, nursing, ondansetron, opiate, over-the-counter drug, physician, prescription drug, psychopharmacology, research, social stigma, specialty (medicine), substance abuse, tetrahydrocannabinol, therapy
David Gordon
Owner at 4 Pillars Health & Wellness
alternative medicine, amphetamine, animal testing, anti-inflammatory, antioxidant, attention deficit hyperactivity disorder, bioavailability, bong, breathing, cannabidiol, cannabinoid, cannabis, cannabis (drug), chylomicron, cytochrome p450, digestion, dispensary, dose (biochemistry), drug test, enzyme, intravenous therapy, kentucky, medical cannabis, medical school, medication, medicine, nursing, ondansetron, opiate, over-the-counter drug, pharmacogenomics, pharmacokinetics, physician, prescription drug, psychopharmacology, research, science, social stigma, specialty (medicine), substance abuse, tetrahydrocannabinol, therapy, vaporizer (inhalation device)
David Turetsky
Sales and Logistics at Shi Farms
alternative medicine, alzheimer's disease, anti-inflammatory, bong, brand, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis sativa, chinese cuisine, cosmetics, dispensary, dose (biochemistry), farm-to-table, food and drug administration, gummy candy, health claim, kentucky, medical cannabis, medical school, medicine, nursing, nutraceutical, ondansetron, opiate, over-the-counter drug, pharmacy, physician, prescription drug, price, psychopharmacology, regulation of food and dietary supplements by the u.s. food and drug administration, research, sleep, social media, social stigma, specialty (medicine), startup company, substance abuse, target market, taste, tetrahydrocannabinol, therapy
Graciela Moreno
Director of Member Engagement at CBD Industry Association
alternative medicine, anti-inflammatory, appetite, audit, board certification, bong, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, central processing unit, chemotherapy, convertible bond, cosmetics, crowdfunding, debenture, debt, dietary supplement, discounting, dispensary, dose (biochemistry), dravet syndrome, education, emergency medical technician, endocannabinoid system, endocrinology, epilepsy, fda food safety modernization act, financial capital, food, food and drug administration, food safety, free market, good manufacturing practice, hair loss, health claim, hormone, interest, interest rate, investment, investor, iso 9000, kentucky, medical cannabis, medical school, medication, medicine, mental disorder, mental health, mergers and acquisitions, mind, nsf international, nursing, obesity, ondansetron, opiate, option (finance), organic certification, over-the-counter drug, paramedic, pathology, pediatrics, physician, prescription drug, probiotic, psychopharmacology, quality management system, regulatory compliance, research, retail, safety, schizophrenia, selective serotonin reuptake inhibitor, sleep, social stigma, specialty (medicine), stock, stock dilution, substance abuse, syndrome, synthetic cannabinoids, tetrahydrocannabinol, therapy, tony montana, traditional chinese medicine, valuation (finance), verification and validation, vitamin c, well-being
Lev Aminov
Director of Formulations at Hemp Farms (Plant Pharma LLC)
blood sugar level, cannabidiol, cannabis (drug), carbohydrate, clinical trial, dietary supplement, disease, dose (biochemistry), drug overdose, emergency department, food, heroin, medical cannabis, medication, neurology, neurosurgery, nicotine, opioid overdose, pharmaceutical industry, pharmacokinetics, surgery, tetrahydrocannabinol, therapy
Adam Abodeely
Board Certified Surgeon & CEO-Founder at ReserveMD
adoption, allosteric modulator, alternative medicine, anesthesia, anticoagulant, antihypertensive drug, appetite, audit, background check, bank, benzodiazepine, best practice, bioavailability, bleeding, bloating, blood sugar level, board certification, brand, breathing, budtender, c-reactive protein, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis sativa, carbohydrate, central processing unit, charlotte's web (cannabis), chemotherapy, chemotherapy-induced nausea and vomiting, clinical trial, commerce clause, controlled substances act, craft brewery and microbrewery, crohn's disease, dementia, depression (mood), diarrhea, dietary supplement, disease, dose (biochemistry), drug, drug development, drug overdose, due diligence, edema, emergency department, endocannabinoid system, entourage effect, fda food safety modernization act, fda warning letter, fibromyalgia, flavonoid, food, food and drug administration, food safety, foodborne illness, gastrointestinal disease, gastroparesis, general surgery, good manufacturing practice, gut–brain axis, headache, heartburn, hemp, hemp oil, heroin, homeostasis, ibuprofen, ileostomy, immune system, indication (medicine), inflammation, inflammatory bowel disease, inhaler, intestinal permeability, iso 9000, lemon, lobbying, lung volumes, macrophage, medical cannabis, medical prescription, medication, mind, morphine, nanotechnology, nausea, neurology, neuron, neurosurgery, neurotransmitter, nicotine, nsf international, nutraceutical, opiate, opioid, opioid epidemic in the united states, opioid overdose, over-the-counter drug, oxycodone, oxycodone/paracetamol, pain, pain management, pathology, patient, personalized medicine, pharmaceutical industry, pharmacogenomics, pharmacokinetics, pharmacology, pharmacy, physician, placebo, placebo-controlled study, polypharmacy, prescription drug, psychoactive drug, quality management system, reason, regulatory compliance, rhabdomyosarcoma, risk, route of administration, safety, scientific method, sensitivity and specificity, serotonin, serotonin syndrome, signal transduction, spasticities, stress (biology), surgery, synthetic cannabinoids, terminal illness, terpene, tetrahydrocannabinol, tetrahydrocannabinol acid, therapeutic index, therapy, toxicity, ulcerative colitis, understanding, verification and validation, warfarin, water
Luis Enrique Weyback
Founder and President at Doctor Jane
absorption (pharmacology), allergy, alzheimer's disease, bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), carbohydrate, chronic stress, chronic traumatic encephalopathy, clinical trial, concussion, cortisol, cortisone, crohn's disease, cytokine, dietary supplement, disease, doping in sport, dose (biochemistry), drug overdose, emergency department, fluid replacement, food, food allergy, gastrointestinal tract, grapefruit–drug interactions, healing, heart, herbal medicine, heroin, hypertension, ibuprofen, inflammation, medical cannabis, medication, medicine, naproxen, neurology, neurosurgery, nicotine, nonsteroidal anti-inflammatory drug, opioid, opioid overdose, pain, pharmaceutical industry, pharmacokinetics, reactive oxygen species, route of administration, stress (biology), surgery, tetrahydrocannabinol, therapy, trpv1, tumor necrosis factor-alpha, vasodilation, wound
Jennah Noegel
Chief Operating Officer at Gruene Cross Health & Wellness
absorption (pharmacology), allergy, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), chronic stress, cortisol, crohn's disease, cytokine, dose (biochemistry), food allergy, gastrointestinal tract, grapefruit–drug interactions, herbal medicine, hypertension, opioid, pain, route of administration, stress (biology), tetrahydrocannabinol, therapy, tumor necrosis factor-alpha
Roger Bryant
Owner at Evolve Distributions
absorption (pharmacology), allergy, bioavailability, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), chronic stress, cortisol, crohn's disease, cytokine, dose (biochemistry), food allergy, gastrointestinal tract, grapefruit–drug interactions, herbal medicine, hypertension, opioid, pain, route of administration, stress (biology), tetrahydrocannabinol, therapy, tumor necrosis factor-alpha
Rob Streisfeld
CEO at BeyondBrands
absorption (pharmacology), allergy, alternative medicine, appetite, bioavailability, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis indica, chemotherapy, chronic stress, cortisol, crohn's disease, cytokine, dose (biochemistry), endocannabinoid system, endocrinology, epilepsy, food allergy, food and drug administration, gastrointestinal tract, grapefruit–drug interactions, herbal medicine, hormone, hypertension, obesity, opioid, pain, probiotic, route of administration, selective serotonin reuptake inhibitor, sleep, stress (biology), synthetic cannabinoids, tetrahydrocannabinol, therapy, traditional chinese medicine, tumor necrosis factor-alpha, vitamin c, well-being
Keiko Beatie
Director of Education & Programming Coral Cove Cannabis Jamaica Holistic Ayurvedic Chinese Medicine at Green Wave Relations
absorption (pharmacology), acne, aesthetics, agriculture, allergy, american broadcasting company, anxiety, anxiety disorder, arthritis, attention, ayurveda, belief, bioavailability, brand, broadcast syndication, cake, cancer, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis sativa, cannabis strain, cbs, certificate of analysis, chemical peel, china, chinese herbology, chronic pain, chronic stress, clinical trial, cortisol, cosmetics, crohn's disease, cytokine, dementia, design, dietary supplement, dose (biochemistry), drug, drug overdose, drug rehabilitation, endocannabinoid system, ethanol, federal aviation administration, flower, food, food allergy, food and drug administration, fox broadcasting company, gastrointestinal tract, good manufacturing practice, grapefruit–drug interactions, grocery store, haircare, health care, heat, hemp, herbal medicine, hypertension, law, lawyer, lotion, medical cannabis, medication, medicine, medium-chain triglyceride, mental disorder, mood (psychology), nbc, news, nutraceutical, opiate, opioid, organic certification, osteoarthritis, packaging and labeling, packaging, and labeling, pain, pain management, percentage, pesticide, pharmaceutical industry, prescription drug, pricing, psilocybin, qr code, reputation, retail, route of administration, runway, seed, separation anxiety disorder, shelf life, soap, solubility, stress (biology), substance dependence, tablet (pharmacy), tea, tetrahydrocannabinol, textbook, therapy, traditional chinese medicine, tumor necrosis factor-alpha, united states department of agriculture, veterinarian
Emek Blair
Founder and Chief Scientist at Puffin Hemp
absorption (pharmacology), bioavailability, blood sugar level, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis, cannabis (drug), carbohydrate, chemist, clinical trial, concussion, cytochrome p450, dietary supplement, disease, dose (biochemistry), drug overdose, emergency department, emotion, enzyme, food, hash oil, heroin, liposome, medical cannabis, medication, memory, micelle, milk, nanotechnology, neuroimaging, neurology, neurosurgery, nicotine, opioid overdose, pharmaceutical industry, pharmacokinetics, receptor (biochemistry), receptor antagonist, surfactant, surgery, tetrahydrocannabinol, therapy
1
1-13 of 13